Location of Repository

Opioids and a Neuro-Vascular-Immune Axis.

By John Parry Williams

Abstract

Opioid-based agents represent the cornerstone of analgesia in modern clinical practice. Additionally however opioids produce a range of unwelcome side-effects including immunomodulation. It has been suggested that this immunomodulation may result either as a direct effect of opioids on circulating immune cells or via a central action. Meanwhile studies show that classical opioid receptors are up-regulated in peripheral inflammation, while endogenous opioids are released from circulating immune cells producing local analgesia. Expression of opioid receptors on immune cells however\ud remains contentious.\ud This thesis has made a significant contribution to understanding the interaction between opioids and a neurovascularimmune axis by employing radioligand binding, flow cytometry and polymerase chain reaction techniques to make a systematic and detailed examination of the expression of the classical opioid receptors (MOP, DOP and KOP) and the non-classical opioid receptor (NOP) and the precursor for its endogenous ligand N/OFQ (ppN/OFQ) in the peripheral blood mononuclear cells (PBMCs) of healthy volunteers. Using these techniques we have shown (1) that naïve human PBMCs do not express classical opioid receptors, (2) that PCR techniques support the view that PBMCs do express gene transcripts for NOP and ppN/OFQ.\ud In an additional clinical study during a profound vascular insult we have used\ud quantitative PCR and radioimmunoassay techniques to follow the expression of the\ud opioid receptors and native N/OFQ throughout a septic episode in patients admitted to the\ud intensive care unit (ICU). Here we report for the first time an elevation in plasma N/OFQ concentration in non-survivors of sepsis requiring ICU admission, 3.0 [2.5 – 5.0]pg ml-1 in non-survivors vs. 1.0 [1.0 – 2.5]pg ml-1 in survivors (p=0.028). Similarly we are first in reporting an elevation in plasma N/OFQ following major abdominal surgery in septic patients.\ud These findings lead us to suggest an amendment to the previously proposed\ud neuroimmune axis to include the N/OFQ-NOP system

Publisher: University of Leicester
Year: 2008
OAI identifier: oai:lra.le.ac.uk:2381/4160

Suggested articles

Preview

Citations

  1. (2002). [Nphe1]nociceptin(1-13)-NH2 antagonizes nociceptin-induced hypotension, bradycardia and hindquarters vasodilatation in the anesthetized rat.
  2. (1999). 125)I]orphanin FQ/nociceptin binding in Raji cells.
  3. (2006). 75 years of opioid research: the exciting but vain quest for the Holy Grail.
  4. (2000). a cellular mechanism for the bi-directional painmodulating actions of orphanin FQ/nociceptin.
  5. (2006). A pharmacology primer. Theory, applications and methods.
  6. (1999). A rough guide to molecular biology.
  7. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
  8. (2001). Acute opioid receptor desensitization and tolerance: is there a link?
  9. (1986). Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.
  10. (1985). APACHE II: a severity of disease classification system. Crit Care Med.
  11. (2003). Cardiovascular responses to microinjections of nociceptin into a midline area in the commissural subnucleus of the nucleus tractus solitarius of the rat. Brain Res. 984:93-103 Shapiro HM.
  12. (2004). Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain.
  13. (1992). Cloning of delta opioid receptor by functional expression.
  14. (2007). Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation.
  15. (2002). Cold stress alters Mytilus edulis pedal ganglia expression of mu opiate receptor transcripts determined by real-time RT-PCR and morphine levels. Brain Res Mol Brain Res.
  16. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity.
  17. Delta opioid receptor gene expression in lymphocytes.
  18. (1992). Delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characerization.
  19. (2000). Detection and function of opioid receptors on cells from the immune system.
  20. (1997). Detection of opioid receptor mRNA by RT-PCR reveals alternative splicing for the delta- and kappa-opioid receptors. Brain Res Mol Brain Res.
  21. (2002). Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set.
  22. (1999). Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation.
  23. (1998). Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells.
  24. (2004). Do Peripheral Blood Mononuclear Cells Express MOP Receptors? A Preliminary Study. Anaesthetic Research Society Meeting
  25. (2006). Drugs of abuse, immune modulation, and AIDS.
  26. (1991). Effect of morphine on growth of metastatic colon cancer in vivo. Arch Surg.
  27. (1997). Effect of nociceptin on heart rate and blood pressure in anaesthetized rats.
  28. (2001). Effect of the opioid remifentanil on cellular immune response in the rat. Int Immunopharmacol.
  29. (2006). Effects of opioid tolerance and withdrawal on the immune system.
  30. (2004). Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.
  31. (1998). Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain.
  32. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med.
  33. (2002). Ethics Committee Amendment 7233 Bibliography Abbas AK, Lichtman AH.2003. Cellular and Molecular Immunology.
  34. (2001). Evidence for an opioid inhibitory effect on T cell proliferation.
  35. (1998). Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action.
  36. (1967). Experimental canine endotoxin shock: failure to correlate outcome with persistent endotoxemia.
  37. (1995). Expression of kappa opioid receptors in human and monkey lymphocytes.
  38. (1997). Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin.
  39. (2002). Function of nociceptin and opioid OP4 receptors in the regulation of the cardiovascular system.
  40. (2004). Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes. Brain Res.
  41. (2003). Human neutrophils as a source of nociceptin: a novel link between pain and inflammation.
  42. (2001). Immune-derived opioids and peripheral antinociception.
  43. (2001). Immunofluorescence detection of delta opioid receptors (DOR) on human peripheral blood CD4+ T cells and DOR-dependent suppression of HIV-1 expression.
  44. (2002). Immunomodulatory activity of orphanin FQ/nociceptin on traumatic rats. Acta Pharmacol Sin.
  45. (1998). Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized muopioid receptors from rat brain: coimmunoprecipitation of the G proteins G(alpha o), G(alpha i1), and G(alpha i3).
  46. (2004). Increased numbers of opioid expressing inflammatory cells do not affect intraarticular morphine analgesia.
  47. (1995). Increased opioid binding to peripheral white blood cells in a rat model of acute cholestasis.
  48. (2000). Interaction of local anaesthetics with recombinant mu, kappa, and delta-opioid receptors expressed in Chinese hamster ovary cells.
  49. (2001). International Sepsis Definitions Conference.
  50. (2008). Kainic Acid Downregulates NOP Receptor Density and Gene Expression in Human Neuroblastoma SHSY5Y Cells.
  51. (2003). Microbial infections, immunomodulation, and drugs of abuse.
  52. (2000). Morphine upregulates mu opioid receptors of human and monkey lymphocytes.
  53. (2004). Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT.
  54. (1994). Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
  55. (1995). Mu opioid receptor gene expression in immune cells.
  56. (2006). Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun.
  57. (1999). Neutrophil function and opioid receptor expression on leucocytes during chronic naltrexone treatment in humans.
  58. (2004). Nociceptin/orphanin FQ modulates human T cell function in
  59. (2008). Nociceptin/orphanin FQ-NOP receptor system as a mediator of sepsis progression.
  60. (2006). Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions.
  61. (2002). Novel orphanin FQ/nociceptin transcripts are expressed in human immune cells.
  62. (1998). Opiate tolerance and dependence: receptors, G-proteins, and antiopiates.
  63. (2002). Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1.
  64. (2001). Opioid peptideexpressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain.
  65. (2002). Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation.
  66. (2000). Opioid Pharmacology. Anaesthesia, Pain and Intensive Care Medicine.
  67. (2006). Opioid receptors and signaling on cells from the immune system.
  68. (2005). Opioid receptors. Contin Educ Anaesth Crit Care Pain.
  69. (2004). Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg.
  70. (2001). Opioids, opioid receptors, and the immune response.
  71. (1998). ORL1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery.
  72. (1995). orphanin FQ; a neuropeptide that activates an opioid like G protein-coupled receptor.
  73. (2001). Orphanin FQ/nociceptin binds to functionally coupled ORL1 receptors on human immune cell lines and alters peripheral blood mononuclear cell proliferation.
  74. (1995). Orphanin-FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor.
  75. (1998). Pain control in inflammation governed by selectins.
  76. (2004). Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood.
  77. (2004). Practical considerations in design of internal amplification controls for diagnostic PCR assays.
  78. (1996). Principles of Physiology.
  79. (1951). Protein measurement with the Folin phenol reagent.
  80. (2005). Quantitative real-time RT-PCR--a perspective.
  81. (2001). Real-time RT-PCR measurement of the modulation of Mu opiate receptor expression by nitric oxide in human mononuclear cells.
  82. (1995). Recent advances in molecular recognition and signal transduction of active peptides.
  83. (2007). receptors: Introduction
  84. (1996). Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists.
  85. (2001). Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site.
  86. (2004). Relation between lymphopenia and bacteraemia in UK adults with medical emergencies.
  87. (2005). Review of Medical Physiology. McGraw-Hill Medical Paperback Gavériaux
  88. (2005). Selection of reference genes for gene expression studies in human neutrophils by real-time PCR.
  89. stimulates human monocyte chemotaxis via NOP receptor activation.
  90. (2004). Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain.
  91. (2004). Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 32:858-73 Despopoulos A, Silbernagl S.
  92. (2003). Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs.
  93. (1999). The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant mu-opioid receptors and SH-SY5Y cells.
  94. (1999). The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro.
  95. (1998). The porcine mu opioid receptor: molecular cloning and mRNA distribution in lymphoid tissues.
  96. (2000). The potential therapeutic value of nociceptin receptor agonists and antagonists.
  97. (2003). The role of the peripheral nervous system in immune cell recruitment.
  98. (2004). Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6. Mol Pharmacol.
  99. (2004). Validation of housekeeping genes for normalizing RNA expression in real-time PCR.
  100. White TJ.1990. PCR Protocols: A Guide to Methods and Applications. Ed Innis M.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.